STOCK TITAN

Gilead Sciences to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Gilead Sciences, Inc. (Nasdaq: GILD) executives to speak at investor conferences. Live webcasts and replays available on investors.gilead.com. Key SEO terms: Gilead Sciences, investor conferences, webcasts, replays, GILD stock, Jefferies London Healthcare Conference, Evercore ISI HealthCONx Conference, Piper Sandler Healthcare Conference.
Positive
  • None.
Negative
  • None.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

  • Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time
  • Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time
  • Piper Sandler Healthcare Conference on Wednesday, November 29 at 9:00am Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Jacquie Ross, CFA – Investors

investor_relations@gilead.com

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) executives will be speaking at investor conferences.

The executives will be speaking at the Jefferies London Healthcare Conference on November 15 at 9:00am Greenwich Mean Time, the Evercore ISI HealthCONx Conference on November 28 at 1:20pm Eastern Time, and the Piper Sandler Healthcare Conference on November 29 at 9:00am Eastern Time.

The live webcasts can be accessed at the company’s investors page at investors.gilead.com.

The replays will be available for at least 30 days following the presentation.
Gilead Sciences, Inc.

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
US
Foster City

About GILD

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.